...
首页> 外文期刊>Surgery >Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
【24h】

Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.

机译:与乙型或丙型肝炎相关的肝细胞癌相比,患有乙型和丙型肝炎相关的肝细胞癌的患者的手术结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose of our study was to report on the surgical outcomes of patients with hepatocellular carcinoma (HCC) with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and to assess the differences in the surgical results between those patients and the patients with hepatitis B- or hepatitis C-related HCC. METHODS: The operative outcomes of 13 patients with hepatitis B surface antigen (HBsAg)-positive and hepatitis C antibody (HCV Ab)-positive (the BC-HCC group) results, 57 patients with HBsAg-positive and HCV Ab-negative (the B-HCC group) results, and 34 patients with HBsAg-negative and HCV Ab-positive (the C-HCC group) results, who had undergone hepatic resection from 1991 to 1995, were compared. RESULTS: The operative mortality rate within 1 month after operation for patients with BC-HCC was 7.7%. No statistically significant difference was found compared with the patients with B-HCC and C-HCC (5.3% and 5.9%, respectively). The postoperative course of patients with BC-HCC was complicated by liver failure, postoperative ascites, and wound infection in one patient each. Also, no statistically significant difference was found among the groups (23.1%, 22.8%, and 20.5% for patients with BC-HCC, B-HCC, and C-HCC, respectively). The overall 1-, 3-, and 5-year survival rates of patients with BC-HCC in this series were 75%, 50%, and 40%, respectively. The postoperative recurrence rate was 66.7%. No statistically significant differences were found between the various groups of the virus-related HCC on the overall survival rate and disease-free survival rate. CONCLUSIONS: Hepatic resection for HCC in patients with dual HBV and HCV infections was associated with slightly higher operative morbidity and mortality rates, but there were no statistical differences compared with hepatitis B- or C-related HCC regarding the survival and recurrence rates.
机译:背景:我们的研究目的是报告合并乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染的肝细胞癌(HCC)患者的手术效果,并评估这些患者之间的手术结果差异以及乙型肝炎或丙型肝炎相关的肝癌患者。方法:13例乙型肝炎表面抗原(HBsAg)阳性和丙型肝炎抗体(HCV Ab)阳性(BC-HCC组)患者的手术结局,57例HBsAg阳性和HCV Ab阴性(比较了B-HCC组)和1991年至1995年接受肝切除的HBsAg阴性和HCV阳性的34例患者(C-HCC组)。结果:BC-HCC患者术后1个月内的手术死亡率为7.7%。与B-HCC和C-HCC患者相比,无统计学差异(分别为5.3%和5.9%)。 BC-HCC患者的术后病程因肝衰竭,术后腹水和每例患者的伤口感染而并发。此外,各组之间也没有统计学上的显着差异(BC-HCC,B-HCC和C-HCC患者分别为23.1%,22.8%和20.5%)。该系列BC-HCC患者的总体1、3和5年生存率分别为75%,50%和40%。术后复发率为66.7%。在总生存率和无病生存率上,与病毒相关的肝癌各组之间没有发现统计学上的显着差异。结论:HBV和HCV双重感染的患者肝癌肝切除术的手术发病率和死亡率略高,但与B或C相关的HCC的生存率和复发率没有统计学差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号